These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 35610299)
41. Immunoinformatics design of multivalent epitope vaccine against monkeypox virus and its variants using membrane-bound, enveloped, and extracellular proteins as targets. Waqas M; Aziz S; Liò P; Khan Y; Ali A; Iqbal A; Khan F; Almajhdi FN Front Immunol; 2023; 14():1091941. PubMed ID: 36776835 [TBL] [Abstract][Full Text] [Related]
43. An integrated multi-pronged reverse vaccinology and biophysical approaches for identification of potential vaccine candidates against Nipah virus. Albutti A Saudi Pharm J; 2023 Dec; 31(12):101826. PubMed ID: 38028215 [TBL] [Abstract][Full Text] [Related]
46. Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model. Hawman DW; Meade-White K; Leventhal S; Appelberg S; Ahlén G; Nikouyan N; Clancy C; Smith B; Hanley P; Lovaglio J; Mirazimi A; Sällberg M; Feldmann H Mol Ther; 2023 Feb; 31(2):387-397. PubMed ID: 36184852 [TBL] [Abstract][Full Text] [Related]
47. Development of multivalent vaccine targeting M segment of Crimean Congo Hemorrhagic Fever Virus (CCHFV) using immunoinformatic approaches. Sana M; Javed A; Babar Jamal S; Junaid M; Faheem M Saudi J Biol Sci; 2022 Apr; 29(4):2372-2388. PubMed ID: 35531180 [TBL] [Abstract][Full Text] [Related]
48. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence. Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241 [TBL] [Abstract][Full Text] [Related]
49. Exploring structural antigens of yellow fever virus to design multi-epitope subunit vaccine candidate by utilizing an immuno-informatics approach. Sura K; Rohilla H; Kumar D; Jakhar R; Ahlawat V; Kaushik D; Dangi M; Chhillar AK J Genet Eng Biotechnol; 2023 Dec; 21(1):161. PubMed ID: 38051433 [TBL] [Abstract][Full Text] [Related]
50. Crimean-Congo Hemorrhagic Fever Virus: Current Advances and Future Prospects of Antiviral Strategies. Dai S; Deng F; Wang H; Ning Y Viruses; 2021 Jun; 13(7):. PubMed ID: 34206476 [TBL] [Abstract][Full Text] [Related]
51. CCHFV vaccine development, current challenges, limitations, and future directions. Ahata B; Akçapınar GB Front Immunol; 2023; 14():1238882. PubMed ID: 37753088 [TBL] [Abstract][Full Text] [Related]
52. Reverse vaccinology assisted design of a novel multi-epitope vaccine to target Wuchereria bancrofti cystatin: An immunoinformatics approach. Das NC; Gupta PSS; Panda SK; Rana MK; Mukherjee S Int Immunopharmacol; 2023 Feb; 115():109639. PubMed ID: 36586276 [TBL] [Abstract][Full Text] [Related]
53. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus. Hawman DW; Meade-White K; Leventhal S; Feldmann F; Okumura A; Smith B; Scott D; Feldmann H Elife; 2021 Jan; 10():. PubMed ID: 33416494 [TBL] [Abstract][Full Text] [Related]
54. Design of a Multi-Epitopes Vaccine against Hantaviruses: An Immunoinformatics and Molecular Modelling Approach. Ismail S; Abbasi SW; Yousaf M; Ahmad S; Muhammad K; Waheed Y Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35335010 [TBL] [Abstract][Full Text] [Related]
55. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Keshtkar-Jahromi M; Kuhn JH; Christova I; Bradfute SB; Jahrling PB; Bavari S Antiviral Res; 2011 May; 90(2):85-92. PubMed ID: 21362441 [TBL] [Abstract][Full Text] [Related]